Percutaneous Tibial Nerve Stimulation (PTNS) for the Treatment of Chronic Anal Fissure

February 29, 2024 updated by: Region Skane

Percutaneous Tibial Nerve Stimulation for Chronic Anal Fissure - a Prospective Study

Chronic anal fissure rarely heals spontaneously. About 50% heal on administration om topical muscle relaxants (e.g. diltiazem) and/or injection of Botulinum toxin, but for the remainder of patients surgery (with lateral internal sphincterotomy or fissurectomy) with subsequent risks of anal incontinence has been the golden standard. Treatment with PTNS (percutaneous tibial nerve stimulation) has been showed to produce healing of chronic anal fissures not responding to topical treatment, thus avoiding the risk for debilitating anal incontinence.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This study will prospectively include 52 patients with chronic anal fissure that have received topical treatment and stool softeners and have all been evaluated by experienced proctological surgeons. The treatment will be given for 10 consecutive work days and then evaluated at 3 and 12 months. If the patients symptoms are unimproved at 3 months alternative treatments will be offered.

Study Type

Interventional

Enrollment (Estimated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Malmo, Sweden
        • Skåne University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Verified anal fissure (Clinical assessement by experienced proctological surgeon)
  • Full conservative treatment has been given

Exclusion Criteria:

  • Inflammatory bowel disease
  • Fistula and/or anal abscess
  • Patients with compromised immunity
  • Pregnancy
  • Treatment with anti-coagulants (not aspirin)
  • Previous irradiation towards pelvic floor
  • Pacemaker or implanted defibrillator

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PTNS
Treatment with PTNS for chronic anal fissure, treatment to be given for 30 minutes during 10 consecutive work Days.
Patients meeting the criteria are treated with PTNS and are evaluated at 3 months and 1 year after end of treatment.
Other Names:
  • Percutaneous Tibial Nerve Stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healing rate
Time Frame: 3 months after treatment
Healing of anal fissure from assessement of clinical and/or data from patient form
3 months after treatment
Healing rate
Time Frame: 12 months after treatment
Healing of anal fissure from assessement of clinical and/or data from patient form
12 months after treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bowel movements
Time Frame: 3 months after treatment
Changes in frequency of bowel emptying and consistency of bowel contents Before and after treatment
3 months after treatment
Bowel movements
Time Frame: 12 months after treatment
Changes in frequency of bowel emptying and consistency of bowel contents Before and after treatment
12 months after treatment
Adverse effects
Time Frame: 3 months after treatment
Reports of adverse effects (subjective/objective)
3 months after treatment
Adverse effects
Time Frame: 12 months after treatment
Reports of adverse effects (subjective/objective)
12 months after treatment
Smoking
Time Frame: 3 months after treatment
Differences in healing rates between smokers and non-smokers
3 months after treatment
Smoking
Time Frame: 12 months after treatment
Differences in healing rates between smokers and non-smokers
12 months after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Louis B Johnson, PhD, Lund University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

October 14, 2020

First Submitted That Met QC Criteria

October 21, 2020

First Posted (Actual)

October 27, 2020

Study Record Updates

Last Update Posted (Actual)

March 1, 2024

Last Update Submitted That Met QC Criteria

February 29, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No intention to make individual participant data available to other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fissure in Ano

Clinical Trials on PTNS

3
Subscribe